Hilja Ibert has over 25 years’ experience from the international diagnostic industry, from which she has an extensive leadership experience. Dr. Ibert has previously held the position as VP International Diagnostic Solutions at Hologic, and several senior positions within Becton Dickinson and bioMerieux. Dr. Ibert also has experience with early stage R&D companies, lastly in her position as CEO for miDiagnostics in Belgium.
Erling Sundrehagen, co-founder of Gentian, holds 25 international patents. He has over the years headed the development of a dozen diagnostic products creating businesses with 1250 employees. From 1984 to 2013 he was the Head of Scientific Projects in Axis-Shield, comprising 3 consortium project in EU framework programs. Dr. Sundrehagen has held several management positions in Axis-Shield pls, Axis Biochemicals AS and Axis Research AS.
Dr. Ibert holds a PhD degree in Nutrition Science from the University of Bonn, Germany.
Dr. Sundrehagen is dr.med.& cand.real (Dr. Med. Sci., M. Sc.) from University of Oslo, Norway.
Njaal Kind has more than 20 years of experience and extended track-record within financial management and reporting, corporate governance and Investor Relation. Kind has served as the CFO for TiZir Ltd in London, England from 2013-2017. Before that, Mr. Kind has been Business Analyst in Eramet Comilog Manganese in Paris, France (2009-2013) and Investment Director in Tinfos AS in Oslo, Norway (2003-2009).
Bård Sundrehagen has for over 25 years worked in different positions in Norwegian medical diagnostics companies. As one of the co-founders of Gentian, he incorporated the first companies in the Gentian Diagnostics family in 2000. Since then Sundrehagen has been the CEO of the group until recently. He also has 6 years’ experience from Alcatel in the telecom industry.
Kind holds a MSc from BI Norwegian Business School.
Sundrehagen holds a BSc in Economics from the University in Oslo, Norway and a business degree from BI Norwegian Business School.